Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.75 GBX | 0.00% | +4.40% | -34.48% |
Apr. 05 | Roquefort cancels fundraise after "unusual" stock movements | AN |
Apr. 05 | Roquefort Therapeutics Shelves Potential Placing Following Unusual Price Movements | MT |
Business Summary
Number of employees: 9
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ajan Reginald
CEO | Chief Executive Officer | 52 | 22-09-15 |
Chairman | 51 | 20-08-16 | |
Armand Keating
CTO | Chief Tech/Sci/R&D Officer | - | 22-09-15 |
Martin Evans
CTO | Chief Tech/Sci/R&D Officer | 83 | 22-09-15 |
Graham Robertson
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Jean Duvall
BRD | Director/Board Member | 63 | 22-04-04 |
Darrin Disley
BRD | Director/Board Member | 57 | 22-09-15 |
Chairman | 51 | 20-08-16 | |
Martin Evans
CTO | Chief Tech/Sci/R&D Officer | 83 | 22-09-15 |
Ajan Reginald
CEO | Chief Executive Officer | 52 | 22-09-15 |
Michael Stein
BRD | Director/Board Member | 60 | 21-03-21 |
Simon Sinclair
BRD | Director/Board Member | 52 | 22-04-19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 129,149,998 | 37,475,657 ( 29.02 %) | 0 | 29.02 % |
Company contact information
Roquefort Therapeutics Plc
Eccleston Yards 25 Eccleston Place
SW1W 9NF, London
+44 20 3918 8633
http://www.roquefortplc.comSector
1st Jan change | Capi. | |
---|---|---|
-34.48% | 7.65M | |
-7.29% | 111B | |
-1.88% | 90.88B | |
+15.14% | 60.96B | |
+0.64% | 58.51B | |
+9.52% | 41.34B | |
+7.57% | 41.32B | |
+16.81% | 34.21B | |
+1.08% | 24.31B | |
-4.87% | 22.02B |
- Stock Market
- Equities
- ROQ Stock
- Company Roquefort Therapeutics plc